Kikuo Kasai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kikuo Kasai has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Yoshiyuki Hattori
Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Japan
5 shared publications Nobuyuki Banba
Department of Endocrinology and Metabolism and
3 shared publicationsAkira Hishinuma
Department of Clinical Pathology, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan
2 shared publicationsHiroyuki Kase
Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Japan
2 shared publicationsKunihiro Suzuki
Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Japan
2 shared publicationsMichiko Matsumura
Department of Endocrinology and Metabolism and
2 shared publications
Latest Publications
- 1 November 2010
- p. 186-9
[Phosphodiesterase-3 inhibitor].
- 24 September 2010
- Published by Elsevier in International Journal of Cardiology
- Vol. 144 (1) , 108-109
Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: Fluvastatin vs. rosuvastatin
- 24 September 2010
- Published by Elsevier in International Journal of Cardiology
- Vol. 144 (1) , 108-109
Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: Fluvastatin vs. rosuvastatin
- 28 September 2006
- p. 134-7
[Werner's syndrome].
- 1 July 2003
- Vol. 61 (7) , 1245-9
[Effect of angiotensin II type 1 receptor antagonist on oxidative stress markers in type 2 diabetic patients with hypertension].
Oxidative stress may play a critical role in the pathogenesis of endothelial dysfunction in patients with diabetes or hypertension. An angiotensin II type 1 receptor(AT1) antagonist candesartan is now a widely used antihypertesive drug, and AT1 activation is a predominant source of oxidative stress. We studied the effect of a 12-week treatment of candesartan(4-12 mg-day) on oxidative stress markers [lipid peroxidation(LPO), malondialdehyde-modified LDL(MDA-LDL), 8-epi-PGF2 alpha, and the generation of superoxide anion by monocytes(CLA-DCL)] in 30 type 2 diabetic patients with hypertension (> 140/85 mmHg). Both MDA-LDL and CLA-DCL were significantly decreased, although the others were not changed. These data suggest that candesartan clinically improves oxidant stress, probably lowering the generation of superoxide anion from blood monocytes.
- 1 July 2003
- Vol. 61 (7) , 1245-9
[Effect of angiotensin II type 1 receptor antagonist on oxidative stress markers in type 2 diabetic patients with hypertension].
Oxidative stress may play a critical role in the pathogenesis of endothelial dysfunction in patients with diabetes or hypertension. An angiotensin II type 1 receptor(AT1) antagonist candesartan is now a widely used antihypertesive drug, and AT1 activation is a predominant source of oxidative stress. We studied the effect of a 12-week treatment of candesartan(4-12 mg-day) on oxidative stress markers [lipid peroxidation(LPO), malondialdehyde-modified LDL(MDA-LDL), 8-epi-PGF2 alpha, and the generation of superoxide anion by monocytes(CLA-DCL)] in 30 type 2 diabetic patients with hypertension (> 140/85 mmHg). Both MDA-LDL and CLA-DCL were significantly decreased, although the others were not changed. These data suggest that candesartan clinically improves oxidant stress, probably lowering the generation of superoxide anion from blood monocytes.
- 1 July 2001
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (7) , 1179-1183
4-Hydroxynonenal Prevents NO Production in Vascular Smooth Muscle Cells by Inhibiting Nuclear Factor-κB–Dependent Transcriptional Activation of Inducible NO Synthase
Abstract —The role of lipid peroxidation products in atherogenesis was studied. We investigated whether 4-hydroxy-2-nonenal (HNE) modulates activation of the nuclear factor (NF)-κB system or alters expression of the NF-κB target gene product, inducible NO synthase (iNOS), in vascular smooth muscle cells (VSMCs) stimulated by lipopolysaccharide (LPS) in combination with interferon (IFN)-γ (LPS/IFN). NO production induced by LPS/IFN was dose-dependently inhibited by HNE. NF-κB activation by LPS/IFN was inhibited by HNE in a dose-dependent manner. HNE significantly decreased LPS/IFN-stimulated proteolysis of IκB-α. iNOS promoter activity stimulated by LPS/IFN was also decreased by HNE dose-dependently. The treatment of VSMCs with LPS/IFN strongly stimulated iNOS mRNA and protein expression. The LPS/IFN-induced increases in iNOS mRNA and protein levels were dose-dependently decreased by HNE. Our data suggest that treatment with HNE blocks signaling events required for IκB-α degradation, thereby preventing NF-κB activation. Inhibition of NF-κB–regulated gene expression, especially modulation of NO production, may contribute to atherogenesis.
- 1 July 2001
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (7) , 1179-1183
4-Hydroxynonenal Prevents NO Production in Vascular Smooth Muscle Cells by Inhibiting Nuclear Factor-κB–Dependent Transcriptional Activation of Inducible NO Synthase
Abstract —The role of lipid peroxidation products in atherogenesis was studied. We investigated whether 4-hydroxy-2-nonenal (HNE) modulates activation of the nuclear factor (NF)-κB system or alters expression of the NF-κB target gene product, inducible NO synthase (iNOS), in vascular smooth muscle cells (VSMCs) stimulated by lipopolysaccharide (LPS) in combination with interferon (IFN)-γ (LPS/IFN). NO production induced by LPS/IFN was dose-dependently inhibited by HNE. NF-κB activation by LPS/IFN was inhibited by HNE in a dose-dependent manner. HNE significantly decreased LPS/IFN-stimulated proteolysis of IκB-α. iNOS promoter activity stimulated by LPS/IFN was also decreased by HNE dose-dependently. The treatment of VSMCs with LPS/IFN strongly stimulated iNOS mRNA and protein expression. The LPS/IFN-induced increases in iNOS mRNA and protein levels were dose-dependently decreased by HNE. Our data suggest that treatment with HNE blocks signaling events required for IκB-α degradation, thereby preventing NF-κB activation. Inhibition of NF-κB–regulated gene expression, especially modulation of NO production, may contribute to atherogenesis.
- 1 December 2000
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 279 (6) , C1859-C1869
15-Deoxy-Δ12,14-prostaglandin J2facilitates thyroglobulin production by cultured human thyrocytes
A cyclopentenone-type prostaglandin, 15-deoxy-Δ12,14-prostaglandin J2(15-d-PGJ2), has been shown to induce the cellular stress response and to be a ligand for the peroxisome proliferator-activated receptor (PPAR)-γ. We studied its effect on the basal and thyrotropin (TSH)-induced production of thyroglobulin (TG) by human thyrocytes cultured in the presence of 10% FBS. In 15-d-PGJ2-treated cells in which the agent itself did not stimulate cAMP production, both the basal production of TG and the response to TSH were facilitated, including the production of TG and cAMP, whereas such production was decreased in untreated cells according to duration of culture. PGD2and PGJ2, which are precursors to 15-d-PGJ2, exhibited an effect similar to 15-d-PGJ2. However, the antidiabetic thiazolidinediones known to be specific ligands for PPAR-γ, and WY-14643, a specific PPAR-α ligand, lacked this effect. 15-d-PGJ2and its precursors, but not the thiazolidinediones, induced gene expression for heme oxygenase-1 (HO-1), a stress-related protein, and strongly inhibited interleukin-1 (IL-1)-induced nitric oxide (NO) production. Cyclopentenone-type PGs have been recently shown to inhibit nuclear factor-κB (NF-κB) activation via a direct and PPAR-independent inhibition of inhibitor-κB kinase, suggesting that, in human thyrocytes, such PGs may inhibit IL-1-induced NO production, possibly via an inhibition of NF-κB activation. On the other hand, sodium arsenite, a known activator of the stress response pathway, induced HO-1 mRNA expression but lacked a promoting effect on TG production. Thus 15-d-PGJ2and its precursors appear to facilitate TG production via a PPAR-independent mechanism and through a different pathway from the cellular stress response that is available to cyclopentenone-type PGs. Our findings reveal a novel role of these PGs associated with thyrocyte differentiation.
- 1 December 2000
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 279 (6) , C1859-C1869
15-Deoxy-Δ12,14-prostaglandin J2facilitates thyroglobulin production by cultured human thyrocytes
A cyclopentenone-type prostaglandin, 15-deoxy-Δ12,14-prostaglandin J2(15-d-PGJ2), has been shown to induce the cellular stress response and to be a ligand for the peroxisome proliferator-activated receptor (PPAR)-γ. We studied its effect on the basal and thyrotropin (TSH)-induced production of thyroglobulin (TG) by human thyrocytes cultured in the presence of 10% FBS. In 15-d-PGJ2-treated cells in which the agent itself did not stimulate cAMP production, both the basal production of TG and the response to TSH were facilitated, including the production of TG and cAMP, whereas such production was decreased in untreated cells according to duration of culture. PGD2and PGJ2, which are precursors to 15-d-PGJ2, exhibited an effect similar to 15-d-PGJ2. However, the antidiabetic thiazolidinediones known to be specific ligands for PPAR-γ, and WY-14643, a specific PPAR-α ligand, lacked this effect. 15-d-PGJ2and its precursors, but not the thiazolidinediones, induced gene expression for heme oxygenase-1 (HO-1), a stress-related protein, and strongly inhibited interleukin-1 (IL-1)-induced nitric oxide (NO) production. Cyclopentenone-type PGs have been recently shown to inhibit nuclear factor-κB (NF-κB) activation via a direct and PPAR-independent inhibition of inhibitor-κB kinase, suggesting that, in human thyrocytes, such PGs may inhibit IL-1-induced NO production, possibly via an inhibition of NF-κB activation. On the other hand, sodium arsenite, a known activator of the stress response pathway, induced HO-1 mRNA expression but lacked a promoting effect on TG production. Thus 15-d-PGJ2and its precursors appear to facilitate TG production via a PPAR-independent mechanism and through a different pathway from the cellular stress response that is available to cyclopentenone-type PGs. Our findings reveal a novel role of these PGs associated with thyrocyte differentiation.
- 8 September 1997
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 238 (1) , 191-196
Production of Granulocyte/Macrophage and Macrophage Colony-Stimulating Factors by Human Thyrocytes in Culture
- 8 September 1997
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 238 (1) , 191-196
Production of Granulocyte/Macrophage and Macrophage Colony-Stimulating Factors by Human Thyrocytes in Culture
- 1 January 1996
- Published by Japan Endocrine Society in Folia Endocrinologica Japonica
- Vol. 72 (1) , 95-106
Effects of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) on the Cardiovascular System in vivo and in vitro
- 1 January 1996
- Published by Japan Endocrine Society in Folia Endocrinologica Japonica
- Vol. 72 (1) , 95-106
Effects of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) on the Cardiovascular System in vivo and in vitro
- 1 January 1994
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 41 (4) , 399-407
Growth Regulation of the Human Papillary Thyroid Cancer Cell Line by Protein Tyrosine Kinase and cAMP-Dependent Protein Kinase.
We established a cell line (hPTC) from the tissue of papillary thyroid cancer surgically excised from a 27-year-old female patient. Synthesis of cAMP by the hPTC cells was stimulated by TSH. This cell line has continued to divide as a monolayer in a tissue culture for three years. We assessed growth regulation of the hPTC cells by protein tyrosine kinase and cAMP-dependent protein kinase by measuring the DNA content of the hPTC cells in 24-well plates with 3,5-diaminobenzoic acid after incubation in various growth factors. Basic fibroblast growth factor (FGF), epidermal growth factor (EGF), and insulin-like growth factor-1 (IGF-1), all of which bind to their respective receptors with tyrosine kinase activity, stimulated DNA synthesis in the hPTC cells. Neutralizing antibodies to basic FGF and EGF suppressed the growth stimulation by basic FGF and EGF, respectively. Genistein, a specific protein tyrosine kinase inhibitor, inhibited proliferation of the hPTC cells. On the other hand, thyrotropin, dibutyryl cAMP (dBC) and forskolin inhibited proliferation. KT5720, a specific cAMP-dependent protein kinase inhibitor, restored the growth of the hPTC cells even in the presence of dBC. This study shows that stimulation of the protein tyrosine kinase activity by basic FGF, EGF, and IGF-1 promoted DNA replication by the human thyroid cancer cell line. However, activation of the cAMP-dependent protein kinase inhibited proliferation of this cell line.
- 1 January 1994
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 41 (4) , 399-407
Growth Regulation of the Human Papillary Thyroid Cancer Cell Line by Protein Tyrosine Kinase and cAMP-Dependent Protein Kinase.
We established a cell line (hPTC) from the tissue of papillary thyroid cancer surgically excised from a 27-year-old female patient. Synthesis of cAMP by the hPTC cells was stimulated by TSH. This cell line has continued to divide as a monolayer in a tissue culture for three years. We assessed growth regulation of the hPTC cells by protein tyrosine kinase and cAMP-dependent protein kinase by measuring the DNA content of the hPTC cells in 24-well plates with 3,5-diaminobenzoic acid after incubation in various growth factors. Basic fibroblast growth factor (FGF), epidermal growth factor (EGF), and insulin-like growth factor-1 (IGF-1), all of which bind to their respective receptors with tyrosine kinase activity, stimulated DNA synthesis in the hPTC cells. Neutralizing antibodies to basic FGF and EGF suppressed the growth stimulation by basic FGF and EGF, respectively. Genistein, a specific protein tyrosine kinase inhibitor, inhibited proliferation of the hPTC cells. On the other hand, thyrotropin, dibutyryl cAMP (dBC) and forskolin inhibited proliferation. KT5720, a specific cAMP-dependent protein kinase inhibitor, restored the growth of the hPTC cells even in the presence of dBC. This study shows that stimulation of the protein tyrosine kinase activity by basic FGF, EGF, and IGF-1 promoted DNA replication by the human thyroid cancer cell line. However, activation of the cAMP-dependent protein kinase inhibited proliferation of this cell line.